Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Heart Journal

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2006.05.004PMID 16996841
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

  2004cited by this paper
• Autoantibodies as predictors of disease.

  2004cited by this paper
• Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation.

  2004cited by this paper
• Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy.

  2004cited by this paper
• Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.

  2004cited by this paper
• Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

  2003cited by this paper
• Dendritic cell–induced autoimmune heart failure requires cooperation between adaptive and innate immunity

  2003cited by this paper
• Specific Removal of β1-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy

  2002cited by this paper
• Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy.

  2002cited by this paper
• Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance

  2002cited by this paper
• Differential Profile and Biochemical Effects of Antiautonomic Membrane Receptor Antibodies in Ventricular Arrhythmias and Sinus Node Dysfunction

  2001cited by this paper
• Infection, mimics, and autoimmune disease.

  2001cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure.

  2001cited by this paper
• Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy.

  2001cited by this paper
• Peptide‐based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities

  2001cited by this paper
• Autoantibodies: emerging upstream targets of arrhythmias and sudden death in patients with idiopathic dilated cardiomyopathy.

  2001cited by this paper
• Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes.

  2001cited by this paper
• Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications.

  2000cited by this paper
• Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies.

  2000cited by this paper
• Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease.

  1999cited by this paper
• Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

  1999cited by this paper
• Idiopathic dilated cardiomyopathy: a superantigen-driven autoimmune disease.

  1998cited by this paper
• Cardiac autoantibodies in dilated cardiomyopathy: a pathogenetic role?

  1997cited by this paper
• Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.

  1996cited by this paper
• Organ-specific cardiac autoantibodies in dilated cardiomyopathy--an update.

  1995cited by this paper
• Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops.

  1995cited by this paper
• Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect.

  1994cited by this paper
• Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

  1993cited by this paper
• Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting.

  1993cited by this paper
• Assessment of immune modulation of beta-adrenergic pathways in human dilated cardiomyopathy: influence of methodologic factors.

  1992cited by this paper
• Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy.

  1985cited by this paper
• Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases.

  1984cited by this paper
• A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity.

  1984cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper
• Applied Regression Analysis

  1966cited by this paper

• Immune Mechanisms of Viral, Autoimmune, and Immune Checkpoint Inhibitor-Associated Myocarditis.

  2026cites this paper
• 2025 Clinical practice guidelines for Myocarditises

  2025cites this paper
• Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: A systematic review and meta-analysis.

  2025cites this paper
• Autonomic Imbalance in Cardiomyopathy and Heart Failure: From Neurobiology to Precision Neuromodulation

  2025cites this paper
• Cardioimmunologic response patterns after an acute heart failure event: Design and first results of AHF‐ImmunoCS

  2025cites this paper
• Quercetin reverses β1-adrenoceptor autoantibody-induced heart failure by promoting MDM2-mediated ubiquitination and degradation of p53 in cardiomyocytes

  2025cites this paper
• Autoimmune Myocarditis, Old Dogs and New Tricks

  2024cites this paper
• Role of T Cells in Viral and Immune-mediated Myocarditis

  2024cites this paper
• B-cells in pulmonary arterial hypertension: friend, foe or bystander?

  2024cites this paper
• Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non‐ischaemic heart failure

  2023cites this paper
• β1 Adrenergic Receptor Autoantibodies and IgG Subclasses: Current Status and Unsolved Issues

  2023influential citation
• The Molecular Role of Immune Cells in Dilated Cardiomyopathy

  2023cites this paper
• JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis.

  2023cites this paper
• β1-adrenergic Receptor Solubilized in the Form of Nanodiscs: Screening of Various Amphipatic Polymers

  2023cites this paper
• Vasoregulatory Autoantibodies and Clinical Outcome After Ischemic Stroke—PROSCIS‐B

  2023cites this paper
• Cardiological Challenges Related to Long-Term Mechanical Circulatory Support for Advanced Heart Failure in Patients with Chronic Non-Ischemic Cardiomyopathy

  2023cites this paper
• S100a9 inhibits Atg9a transcription and participates in suppression of autophagy in cardiomyocytes induced by β1-adrenoceptor autoantibodies

  2023cites this paper
• Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy

  2022cites this paper
• The Role of B Cells in Cardiomyopathy and Heart Failure

  2022cites this paper
• The abnormal distribution of peripheral B1 cells and transition B cells in patients with idiopathic dilated cardiomyopathy: a pilot study

  2022cites this paper
• The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling

  2021cites this paper
• 2020 Clinical practice guidelines for Myocarditis in adults

  2021cites this paper
• Role of Anti-Beta-1-Adrenergic Receptor Antibodies in Cardiac Dysfunction in Patients with Cirrhotic Cardiomyopathy

  2021cites this paper
• β1-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications.

  2020cites this paper
• Myocarditis and Dilated Cardiomyopathy

  2020cites this paper
• Intravenous Immunoglobulin Therapy in Myocarditis.

  2020cites this paper
• Autoantibodies to β1-adrenergic receptor: pathogenetic role, mechanisms of action and methods of determination

  2020cites this paper
• The IgG3 Subclass of β1-adrenergic receptor autoantibody is an endogenous biaser of β1AR signaling

  2020cites this paper
• Autoantibodies against M5-muscarinic and beta1-adrenergic receptors in periodontitis patients

  2020cites this paper
• The role of B cells in heart failure and implications for future immunomodulatory treatment strategies

  2020cites this paper
• Unmasking features of the auto‐epitope essential for β1‐adrenoceptor activation by autoantibodies in chronic heart failure

  2020cites this paper
• Organ-Specific Autoimmune Myocarditis

  2020cites this paper
• Functional autoantibody diseases: Basics and treatment related to cardiomyopathies.

  2019cites this paper
• Diagnostic and prognostic value of autoantibodies against β1-adrenoreceptors in patients with heart failure following acute myocardial infarction: A 5-year prospective study

  2019influential citation
• Autoantikörper gegen herzspezifische Antigene

  2019cites this paper
• Nanodiscs Incorporating Native β1 Adrenergic Receptor as a Novel Approach for the Detection of Pathological Autoantibodies in Patients with Dilated Cardiomyopathy.

  2019cites this paper
• T Cell recruitment to the heart: friendly guests or unwelcome visitors?

  2019cites this paper
• Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy

  2019cites this paper
• Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling

  2019cites this paper
• Anti-ß1-Adrenoreceptor auto-Antibodies in elderly heart failure patients.

  2019cites this paper
• Lethal immunoglobulins: Autoantibodies and sudden cardiac death.

  2019cites this paper
• Adaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling

  2019cites this paper
• Autoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patients

  2018cites this paper
• Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure

  2018cites this paper
• Antibodies aggravate the development of ischemic heart failure.

  2018cites this paper
• Autoantibodies for Cardiac Channels and Sudden Cardiac Death and its Relationship to Autoimmune Disorders

  2018cites this paper
• GPCR-autoantibodies in chronic heart failure.

  2018cites this paper
• Relevant effects of beta1-adrenoceptor autoantibodies in chronic heart failure.

  2018cites this paper
• Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy

  2018cites this paper
• Antibodies to receptors are associated with biomarkers of inflammation and myocardial damage in heart failure.

  2018cites this paper
• Regulatory Role of CD4+ T Cells in Myocarditis

  2018cites this paper
• Organ-Specific Autoimmune Myocardial Diseases: From Pathogenesis to Diagnosis and Management

  2017cites this paper
• Autoantibodies Directed Against G-Protein-Coupled Receptors in Cardiovascular Diseases: Basics and Diagnostics

  2017cites this paper
• The prognostic value of autoantibodies against &bgr;1-adrenoceptor and cardiac troponin-I for clinical outcomes in STEMI

  2017cites this paper
• The Immunology of Cardiovascular Homeostasis and Pathology

  2017cites this paper
• Cardiomyopathy - An approach to the autoimmune background.

  2017cites this paper
• Lymphocytes at the Heart of Wound Healing.

  2017cites this paper
• MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression

  2017cites this paper
• Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1-Adrenergic Receptors.

  2017cites this paper
• Autoantibodies against β1‐Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function

  2016cites this paper
• Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.

  2016cites this paper
• Associations Between TIM1 Polymorphisms and Dilated Cardiomyopathy in a Han Chinese Population.

  2016cites this paper
• A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease

  2016cites this paper
• [Role of Autoantibodies Against 1-Adrenergic Receptor in Cardiovascular Disease].

  2016cites this paper
• [Detection of Autoantibodies Against the 1-Adrenergic Receptor in the Sera of Patients via the Competitive cell-Based Enzyme Linked Immunosorbent Assay].

  2016cites this paper
• Effects of JNJ-54452840, an Anti-ò1 Receptor Antibody Cyclopeptidein Heart Failure Patients: A Randomized, Double-blind, Parallel-group,Phase-2 Pilot Study

  2016cites this paper
• Dilated Cardiomyopathy in a Han Chinese Population

  2016cites this paper
• Genetic and Potential Autoimmune Triggers of Primary Aldosteronism

  2015cites this paper
• Long QT Syndrome: An Emerging Role for Inflammation and Immunity

  2015cites this paper
• Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study.

  2015cites this paper
• Novel Receptor-Derived Cyclopeptides to Treat Heart Failure Caused by Anti-β1-Adrenoceptor Antibodies in a Human-Analogous Rat Model

  2015influential citation
• Questionable Validity of Peptide-Based ELISA Strategies in the Diagnostics of Cardiopathogenic Autoantibodies That Activate G-Protein-Coupled Receptors

  2015cites this paper
• Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.

  2015cites this paper
• Pilot the pulse: controlling the multiplicity of receptor dynamics.

  2014cites this paper
• Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease.

  2014cites this paper
• Autoantibodies and Cardiovascular Dysfunction: Cause or Consequence?

  2014cites this paper
• Levels of circulating anti-muscarinic and anti-adrenergic antibodies and their effect on cardiac arrhythmias and dysautonomia in murine models of Chagas disease

  2014cites this paper
• Relevance of antibodies targeting the β1-adrenergic receptor for renal function

  2014cites this paper
• Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

  2013cites this paper
• Immunadsorption therapy for end stage heart failure due to Duchenne muscular dystrophy

  2013cites this paper
• Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management

  2013cites this paper
• Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.

  2013cites this paper
• How can we cure a heart “in flame”? A translational view on inflammation in heart failure

  2013cites this paper
• Targeting anti‐beta‐1‐adrenergic receptor antibodies for dilated cardiomyopathy

  2013cites this paper
• Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans

  2013cites this paper
• The Clinical Significance of Anti-Beta-1 Adrenergic Receptor Autoantibodies in Cardiac Disease

  2013influential citation
• Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor

  2013cites this paper
• Administration of the cyclic peptide COR‐1 in humans (phase I study): ex vivo measurements of anti‐β1‐adrenergic receptor antibody neutralization and of immune parameters

  2012cites this paper
• Long‐term benefits of immunoadsorption in β1‐adrenoceptor autoantibody‐positive transplant candidates with dilated cardiomyopathy

  2012cites this paper
• Antibodies to cardiac receptors

  2012cites this paper
• The predictive values of beta1‐adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure

  2012influential citation
• Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.

  2012cites this paper
• Detection of Anti–&bgr;1-AR Autoantibodies in Heart Failure by a Cell-Based Competition ELISA

  2012cites this paper
• Interleukin-6-deficient mice resist development of experimental autoimmune cardiomyopathy induced by immunization of β1-adrenergic receptor.

  2012cites this paper
• New Methods in Cardiovascular Biology Detection of Anti-1-AR Autoantibodies in Heart Failure by a Cell-Based Competition ELISA

  2012cites this paper
• Autoantibodies to Autonomic Neurotransmitter Receptors – A Unique Pathway of Neuro-Immune Interactions

  2012cites this paper
• Pathogenesis and diagnosis of myocarditis

  2012cites this paper
• Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function

  2012influential citation
• TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE

  2012cites this paper
• Republished: Pathogenesis and diagnosis of myocarditis

  2012cites this paper